Gene Symbol | Gene ID | Gene Info |
---|---|---|
Egr1
|
ENSMUSG00000038418.7 | early growth response 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_34865352_34865513 | Egr1 | 4225 | 0.162022 | 0.96 | 2.0e-03 | Click! |
chr18_34864822_34864973 | Egr1 | 3690 | 0.170501 | 0.94 | 6.0e-03 | Click! |
chr18_34864196_34864456 | Egr1 | 3119 | 0.184293 | 0.92 | 8.9e-03 | Click! |
chr18_34865609_34865784 | Egr1 | 4489 | 0.158839 | 0.89 | 1.9e-02 | Click! |
chr18_34861748_34862170 | Egr1 | 752 | 0.571254 | 0.89 | 1.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_107688566_107688742 | 33.69 |
Helz |
helicase with zinc finger domain |
15694 |
0.16 |
chr9_105878487_105878719 | 32.92 |
Col6a5 |
collagen, type VI, alpha 5 |
3203 |
0.27 |
chr16_95769794_95769976 | 32.71 |
Gm37259 |
predicted gene, 37259 |
10049 |
0.17 |
chr2_144224428_144224595 | 31.21 |
Gm5535 |
predicted gene 5535 |
16521 |
0.11 |
chr16_30257794_30257955 | 30.82 |
Gm49645 |
predicted gene, 49645 |
2722 |
0.2 |
chr10_75051471_75051652 | 30.36 |
Bcr |
BCR activator of RhoGEF and GTPase |
9031 |
0.15 |
chr9_73050700_73050869 | 27.09 |
Rab27a |
RAB27A, member RAS oncogene family |
5800 |
0.09 |
chr8_106640189_106640344 | 26.74 |
Cdh1 |
cadherin 1 |
36123 |
0.13 |
chr5_103592755_103593053 | 26.47 |
Gm15844 |
predicted gene 15844 |
31567 |
0.12 |
chr10_20632249_20632430 | 26.02 |
Gm17230 |
predicted gene 17230 |
6704 |
0.26 |
chr7_80462845_80462996 | 25.47 |
Blm |
Bloom syndrome, RecQ like helicase |
957 |
0.48 |
chr17_35549631_35549795 | 24.53 |
Cdsn |
corneodesmosin |
2415 |
0.12 |
chr17_45811998_45812149 | 24.44 |
Gm35692 |
predicted gene, 35692 |
10250 |
0.16 |
chr1_52388262_52388419 | 24.04 |
Gm23460 |
predicted gene, 23460 |
56204 |
0.11 |
chr1_52597910_52598075 | 23.72 |
Gm5527 |
predicted gene 5527 |
13474 |
0.13 |
chr17_56583583_56583743 | 23.53 |
Safb2 |
scaffold attachment factor B2 |
617 |
0.5 |
chr8_120832109_120832260 | 22.81 |
Gm26878 |
predicted gene, 26878 |
48022 |
0.12 |
chr19_55505247_55505422 | 22.80 |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
124320 |
0.06 |
chr18_10934499_10934650 | 21.85 |
Gm7575 |
predicted gene 7575 |
5690 |
0.24 |
chr12_25132144_25132315 | 20.10 |
Gm17746 |
predicted gene, 17746 |
3055 |
0.22 |
chr10_59911193_59911356 | 19.96 |
Dnajb12 |
DnaJ heat shock protein family (Hsp40) member B12 |
31648 |
0.12 |
chr5_115491812_115492014 | 19.67 |
Gm13836 |
predicted gene 13836 |
542 |
0.51 |
chr8_125133982_125134146 | 19.57 |
Disc1 |
disrupted in schizophrenia 1 |
46077 |
0.14 |
chr5_137398768_137398919 | 19.49 |
Zan |
zonadhesin |
2895 |
0.15 |
chr5_119295643_119295794 | 19.10 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
1527 |
0.52 |
chr7_27478150_27478347 | 18.91 |
Sertad3 |
SERTA domain containing 3 |
4480 |
0.1 |
chr1_37026954_37027105 | 18.80 |
Vwa3b |
von Willebrand factor A domain containing 3B |
433 |
0.82 |
chr14_45561878_45562029 | 18.17 |
Gm15601 |
predicted gene 15601 |
1881 |
0.17 |
chr14_54897515_54897687 | 18.07 |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
2768 |
0.09 |
chr16_90402615_90402775 | 17.97 |
Hunk |
hormonally upregulated Neu-associated kinase |
2151 |
0.29 |
chr9_84977601_84977752 | 17.89 |
Gm8228 |
predicted gene 8228 |
1161 |
0.55 |
chr11_80453320_80453471 | 17.88 |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
2973 |
0.25 |
chr18_60625385_60625536 | 17.59 |
Synpo |
synaptopodin |
887 |
0.57 |
chr7_145040977_145041172 | 17.40 |
Ccnd1 |
cyclin D1 |
101149 |
0.06 |
chr5_31094948_31095145 | 17.35 |
Gm9924 |
predicted gene 9924 |
60 |
0.72 |
chr5_90424675_90424898 | 17.04 |
Gm43363 |
predicted gene 43363 |
27513 |
0.13 |
chr5_134155757_134155938 | 17.01 |
Rcc1l |
reculator of chromosome condensation 1 like |
12413 |
0.13 |
chr5_151412960_151413135 | 16.73 |
1700028E10Rik |
RIKEN cDNA 1700028E10 gene |
6521 |
0.17 |
chr1_36603408_36603559 | 16.63 |
Gm6428 |
predicted pseudogene 6428 |
1681 |
0.22 |
chr6_125575019_125575372 | 16.54 |
Vwf |
Von Willebrand factor |
8944 |
0.21 |
chr9_32718091_32718269 | 16.53 |
Gm27240 |
predicted gene 27240 |
7009 |
0.2 |
chr1_133296542_133296715 | 16.47 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
1323 |
0.33 |
chr1_39650381_39650532 | 16.24 |
D930019O06Rik |
RIKEN cDNA D930019O06 |
280 |
0.82 |
chr8_84978044_84978195 | 16.22 |
Junb |
jun B proto-oncogene |
599 |
0.41 |
chr19_58446356_58446507 | 16.21 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
8035 |
0.23 |
chr17_24443544_24443715 | 16.11 |
Dnase1l2 |
deoxyribonuclease 1-like 2 |
524 |
0.46 |
chr3_68508770_68508933 | 16.04 |
Schip1 |
schwannomin interacting protein 1 |
14643 |
0.22 |
chr17_5091628_5091779 | 15.96 |
Gm15599 |
predicted gene 15599 |
20407 |
0.23 |
chr15_102245447_102245598 | 15.75 |
Rarg |
retinoic acid receptor, gamma |
291 |
0.81 |
chr8_105518182_105518333 | 15.61 |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
498 |
0.63 |
chr1_58056967_58057118 | 15.47 |
Aox1 |
aldehyde oxidase 1 |
27078 |
0.14 |
chr15_100112289_100112692 | 15.17 |
4930478M13Rik |
RIKEN cDNA 4930478M13 gene |
4329 |
0.17 |
chr9_61347110_61347271 | 15.03 |
Gm10655 |
predicted gene 10655 |
24437 |
0.16 |
chr1_171382425_171382584 | 14.88 |
Arhgap30 |
Rho GTPase activating protein 30 |
6450 |
0.07 |
chr16_24895224_24895375 | 14.71 |
Gm22672 |
predicted gene, 22672 |
11126 |
0.24 |
chr17_23675280_23675431 | 14.57 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
1198 |
0.16 |
chr9_121435690_121435841 | 14.28 |
Trak1 |
trafficking protein, kinesin binding 1 |
18531 |
0.17 |
chr6_28891682_28891856 | 14.16 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
11726 |
0.21 |
chr4_117116805_117116956 | 14.08 |
Ptch2 |
patched 2 |
3456 |
0.09 |
chr16_43979496_43979654 | 13.99 |
Zdhhc23 |
zinc finger, DHHC domain containing 23 |
216 |
0.92 |
chr11_97958258_97958415 | 13.93 |
Gm11633 |
predicted gene 11633 |
10456 |
0.1 |
chr1_155112239_155112390 | 13.68 |
Ier5 |
immediate early response 5 |
12678 |
0.14 |
chr7_28862945_28863096 | 13.64 |
Lgals7 |
lectin, galactose binding, soluble 7 |
833 |
0.39 |
chr4_43234117_43234284 | 13.62 |
Unc13b |
unc-13 homolog B |
393 |
0.84 |
chr3_37860164_37860325 | 13.61 |
Gm42753 |
predicted gene 42753 |
18446 |
0.14 |
chr14_118923057_118923208 | 13.47 |
Dzip1 |
DAZ interacting protein 1 |
35 |
0.97 |
chr12_98739490_98739641 | 13.46 |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
2160 |
0.2 |
chr9_43748274_43748468 | 13.44 |
Gm30015 |
predicted gene, 30015 |
2271 |
0.24 |
chr4_128804978_128805273 | 13.35 |
Zfp362 |
zinc finger protein 362 |
920 |
0.55 |
chr12_104798236_104798545 | 13.34 |
Clmn |
calmin |
17519 |
0.19 |
chr5_137741641_137741817 | 13.33 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
122 |
0.92 |
chr11_82858816_82858975 | 13.22 |
Rffl |
ring finger and FYVE like domain containing protein |
11849 |
0.1 |
chrX_140524377_140524528 | 13.01 |
Tsc22d3 |
TSC22 domain family, member 3 |
18216 |
0.18 |
chr4_9642210_9642373 | 12.96 |
Asph |
aspartate-beta-hydroxylase |
1426 |
0.46 |
chr18_10934837_10934988 | 12.93 |
Gm7575 |
predicted gene 7575 |
6028 |
0.24 |
chr17_14200076_14200227 | 12.87 |
Gm34510 |
predicted gene, 34510 |
3577 |
0.2 |
chr13_64162320_64162539 | 12.85 |
Habp4 |
hyaluronic acid binding protein 4 |
183 |
0.91 |
chr12_84178717_84179096 | 12.80 |
Gm19327 |
predicted gene, 19327 |
8900 |
0.1 |
chr5_75046920_75047087 | 12.74 |
Gm18593 |
predicted gene, 18593 |
1476 |
0.27 |
chr2_148685098_148685392 | 12.70 |
Gzf1 |
GDNF-inducible zinc finger protein 1 |
633 |
0.66 |
chr11_115212171_115212324 | 12.43 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
24388 |
0.09 |
chr4_155028352_155028518 | 12.12 |
Plch2 |
phospholipase C, eta 2 |
9003 |
0.13 |
chr19_45046611_45046771 | 12.10 |
Sfxn3 |
sideroflexin 3 |
812 |
0.36 |
chr1_133908470_133908621 | 12.07 |
Optc |
opticin |
546 |
0.66 |
chr8_33653901_33654202 | 12.06 |
Gsr |
glutathione reductase |
813 |
0.57 |
chr2_94273299_94273450 | 12.04 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8456 |
0.15 |
chr10_63413658_63413825 | 11.91 |
Gm7530 |
predicted gene 7530 |
742 |
0.56 |
chr2_45411942_45412116 | 11.75 |
Gm13479 |
predicted gene 13479 |
54764 |
0.15 |
chr5_63964660_63964830 | 11.65 |
Rell1 |
RELT-like 1 |
4078 |
0.19 |
chr1_125458645_125458813 | 11.61 |
Gm28706 |
predicted gene 28706 |
14162 |
0.23 |
chr7_19955922_19956099 | 11.60 |
Rpl7a-ps8 |
ribosomal protein L7A, pseudogene 8 |
2227 |
0.14 |
chr18_76301148_76301315 | 11.45 |
Gm50360 |
predicted gene, 50360 |
20593 |
0.19 |
chr7_30478163_30478314 | 11.41 |
Nphs1 |
nephrosis 1, nephrin |
373 |
0.64 |
chr18_60619666_60619817 | 11.29 |
Synpo |
synaptopodin |
3584 |
0.21 |
chr9_46049413_46049714 | 11.24 |
Sik3 |
SIK family kinase 3 |
36563 |
0.11 |
chr6_67088817_67089020 | 11.20 |
E230016M11Rik |
RIKEN cDNA E230016M11 gene |
12158 |
0.14 |
chr7_100042239_100042447 | 11.16 |
Chrdl2 |
chordin-like 2 |
20244 |
0.14 |
chr6_88906225_88906807 | 11.11 |
Tpra1 |
transmembrane protein, adipocyte asscociated 1 |
475 |
0.7 |
chr2_168518274_168518450 | 10.94 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
33914 |
0.18 |
chr15_77842610_77842777 | 10.93 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
518 |
0.7 |
chr16_96081781_96082079 | 10.93 |
Brwd1 |
bromodomain and WD repeat domain containing 1 |
498 |
0.54 |
chr17_45595822_45596123 | 10.88 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
15 |
0.95 |
chr7_46830137_46830394 | 10.87 |
Gm45308 |
predicted gene 45308 |
2199 |
0.15 |
chr13_111871751_111871982 | 10.83 |
Gm15326 |
predicted gene 15326 |
726 |
0.58 |
chr1_165772571_165772722 | 10.77 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
3170 |
0.12 |
chr7_65737343_65737722 | 10.76 |
Tm2d3 |
TM2 domain containing 3 |
44008 |
0.12 |
chr18_81242035_81242186 | 10.72 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
6044 |
0.24 |
chr15_78437022_78437183 | 10.71 |
Kctd17 |
potassium channel tetramerisation domain containing 17 |
3120 |
0.13 |
chr9_70827748_70828187 | 10.70 |
Gm3436 |
predicted pseudogene 3436 |
24609 |
0.16 |
chr11_119035192_119035358 | 10.63 |
Cbx8 |
chromobox 8 |
5556 |
0.17 |
chr10_78069515_78069977 | 10.63 |
Icosl |
icos ligand |
386 |
0.78 |
chr4_144981227_144981590 | 10.58 |
Vps13d |
vacuolar protein sorting 13D |
2553 |
0.3 |
chr6_72743864_72744051 | 10.55 |
Gm37736 |
predicted gene, 37736 |
7957 |
0.16 |
chr9_55225732_55226034 | 10.52 |
Fbxo22 |
F-box protein 22 |
12220 |
0.16 |
chr16_17307555_17307706 | 10.51 |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
100 |
0.95 |
chr3_87556394_87556545 | 10.49 |
ETV3L |
ets variant 3-like |
5220 |
0.18 |
chr1_133182438_133182599 | 10.34 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
1197 |
0.46 |
chr9_118927011_118927199 | 10.25 |
Ctdspl |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
243 |
0.77 |
chr12_3858258_3858439 | 10.23 |
Dnmt3a |
DNA methyltransferase 3A |
2673 |
0.24 |
chr1_164788357_164788561 | 10.21 |
Dpt |
dermatopontin |
8185 |
0.18 |
chr12_110866355_110866579 | 10.19 |
Mpc1-ps |
mitochondrial pyruvate carrier 1, pseudogene |
7573 |
0.09 |
chr5_120643893_120644074 | 10.16 |
Gm42657 |
predicted gene 42657 |
2362 |
0.13 |
chr19_42610535_42610705 | 10.13 |
Loxl4 |
lysyl oxidase-like 4 |
2089 |
0.31 |
chr10_108612751_108612908 | 10.10 |
Syt1 |
synaptotagmin I |
24135 |
0.23 |
chr7_49358786_49358938 | 10.09 |
Nav2 |
neuron navigator 2 |
5859 |
0.24 |
chr2_155592205_155592416 | 10.09 |
Gssos1 |
glutathione synthase, opposite strand 1 |
9 |
0.7 |
chr19_47222639_47222810 | 10.01 |
Gm50339 |
predicted gene, 50339 |
815 |
0.48 |
chr4_150372166_150372459 | 9.85 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
34082 |
0.15 |
chrX_103738847_103739025 | 9.74 |
Slc16a2 |
solute carrier family 16 (monocarboxylic acid transporters), member 2 |
4747 |
0.14 |
chr4_44172816_44172976 | 9.68 |
Rnf38 |
ring finger protein 38 |
4557 |
0.2 |
chr17_3794450_3794609 | 9.67 |
Nox3 |
NADPH oxidase 3 |
98268 |
0.08 |
chr13_74121256_74121414 | 9.63 |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
122 |
0.96 |
chr12_84192763_84192978 | 9.62 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
1145 |
0.32 |
chr2_24311684_24311860 | 9.61 |
Gm13411 |
predicted gene 13411 |
10652 |
0.12 |
chr9_121297685_121297875 | 9.59 |
Trak1 |
trafficking protein, kinesin binding 1 |
49 |
0.97 |
chr7_143784016_143784436 | 9.57 |
Mrgpre |
MAS-related GPR, member E |
274 |
0.84 |
chr5_101703479_101703660 | 9.57 |
9430085M18Rik |
RIKEN cDNA 9430085M18 gene |
17 |
0.9 |
chr7_143779216_143779367 | 9.56 |
Gm22064 |
predicted gene, 22064 |
799 |
0.46 |
chr8_67948591_67948742 | 9.56 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3213 |
0.28 |
chr10_127266714_127266905 | 9.54 |
Dctn2 |
dynactin 2 |
422 |
0.63 |
chr17_86661961_86662112 | 9.47 |
Gm18832 |
predicted gene, 18832 |
23460 |
0.19 |
chr2_91130312_91130482 | 9.45 |
Madd |
MAP-kinase activating death domain |
8859 |
0.11 |
chr4_76284751_76284961 | 9.45 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
40387 |
0.21 |
chr7_19933327_19933498 | 9.44 |
Igsf23 |
immunoglobulin superfamily, member 23 |
11486 |
0.07 |
chr14_46606657_46607000 | 9.27 |
Gm18761 |
predicted gene, 18761 |
724 |
0.53 |
chr10_20285755_20285929 | 9.22 |
Gm48249 |
predicted gene, 48249 |
784 |
0.5 |
chr11_121082992_121083151 | 9.21 |
Sectm1a |
secreted and transmembrane 1A |
1851 |
0.17 |
chr15_82290409_82290560 | 9.17 |
Septin3 |
septin 3 |
6054 |
0.09 |
chr3_132941157_132941316 | 9.15 |
Gm23196 |
predicted gene, 23196 |
1366 |
0.39 |
chr4_41546048_41546413 | 9.08 |
Fam219a |
family with sequence similarity 219, member A |
21460 |
0.09 |
chr2_31825447_31825664 | 9.06 |
Qrfp |
pyroglutamylated RFamide peptide |
14975 |
0.13 |
chr6_122826334_122826673 | 9.05 |
Foxj2 |
forkhead box J2 |
172 |
0.9 |
chr12_80598944_80599110 | 9.00 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
924 |
0.35 |
chr13_107619512_107619663 | 8.97 |
Gm32090 |
predicted gene, 32090 |
6738 |
0.24 |
chr1_134513989_134514156 | 8.96 |
Gm15454 |
predicted gene 15454 |
4009 |
0.12 |
chr1_7089053_7089220 | 8.90 |
Pcmtd1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 |
30 |
0.97 |
chr11_70213843_70214036 | 8.89 |
Slc16a11 |
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
29 |
0.93 |
chr1_86442562_86442744 | 8.86 |
Tex44 |
testis expressed 44 |
16324 |
0.11 |
chr7_96565958_96566109 | 8.84 |
Tenm4 |
teneurin transmembrane protein 4 |
43635 |
0.16 |
chr6_100062035_100062186 | 8.83 |
Gm33201 |
predicted gene, 33201 |
70895 |
0.1 |
chr17_80051656_80051839 | 8.79 |
Gpx4-ps1 |
glutathione peroxidase 4, pseudogene 1 |
2279 |
0.23 |
chr7_3611086_3611255 | 8.79 |
Oscar |
osteoclast associated receptor |
4915 |
0.08 |
chr9_120731019_120731170 | 8.71 |
Gm47064 |
predicted gene, 47064 |
20049 |
0.12 |
chr8_84705414_84705592 | 8.64 |
Nfix |
nuclear factor I/X |
2213 |
0.16 |
chr13_74166717_74166944 | 8.61 |
Exoc3 |
exocyst complex component 3 |
7617 |
0.19 |
chr9_63702505_63702656 | 8.60 |
Smad3 |
SMAD family member 3 |
9389 |
0.23 |
chr18_32239390_32239541 | 8.58 |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
835 |
0.63 |
chr5_134544632_134544783 | 8.58 |
Gm42884 |
predicted gene 42884 |
7350 |
0.1 |
chr7_79847184_79847406 | 8.42 |
Anpep |
alanyl (membrane) aminopeptidase |
888 |
0.44 |
chr7_15948297_15948583 | 8.42 |
Nop53 |
NOP53 ribosome biogenesis factor |
2366 |
0.16 |
chr9_44289013_44289164 | 8.40 |
Abcg4 |
ATP binding cassette subfamily G member 4 |
473 |
0.55 |
chr2_144441501_144441698 | 8.39 |
Zfp133-ps |
zinc finger protein 133, pseudogene |
17681 |
0.14 |
chr2_34407224_34407388 | 8.33 |
Mapkap1 |
mitogen-activated protein kinase associated protein 1 |
123 |
0.96 |
chr2_164432754_164432917 | 8.29 |
Sdc4 |
syndecan 4 |
10351 |
0.08 |
chr5_32735922_32736077 | 8.22 |
Gm43695 |
predicted gene 43695 |
3335 |
0.14 |
chr10_8447769_8447929 | 8.18 |
Ust |
uronyl-2-sulfotransferase |
70976 |
0.12 |
chr11_16704048_16704199 | 8.14 |
Gm25698 |
predicted gene, 25698 |
28588 |
0.15 |
chr7_145087928_145088130 | 8.12 |
Gm45181 |
predicted gene 45181 |
74967 |
0.09 |
chr12_112588513_112588675 | 8.12 |
Inf2 |
inverted formin, FH2 and WH2 domain containing |
190 |
0.93 |
chr15_6707785_6707941 | 8.10 |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
516 |
0.81 |
chr15_83704064_83704215 | 8.08 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
20787 |
0.2 |
chr6_49166228_49166608 | 8.07 |
Gm18010 |
predicted gene, 18010 |
6341 |
0.17 |
chr10_85188162_85188342 | 8.07 |
Cry1 |
cryptochrome 1 (photolyase-like) |
3188 |
0.26 |
chr1_45837784_45838101 | 8.07 |
Gm28906 |
predicted gene 28906 |
1154 |
0.39 |
chr14_122082959_122083124 | 8.05 |
Gm49236 |
predicted gene, 49236 |
8185 |
0.14 |
chr13_58453040_58453215 | 8.04 |
Gm47918 |
predicted gene, 47918 |
10106 |
0.16 |
chr8_114671350_114671501 | 7.99 |
Gm16117 |
predicted gene 16117 |
29311 |
0.17 |
chr2_152414766_152414920 | 7.95 |
Zcchc3 |
zinc finger, CCHC domain containing 3 |
184 |
0.8 |
chr11_120190042_120190216 | 7.94 |
2810410L24Rik |
RIKEN cDNA 2810410L24 gene |
277 |
0.84 |
chr11_51640853_51641004 | 7.91 |
Rmnd5b |
required for meiotic nuclear division 5 homolog B |
5032 |
0.13 |
chr1_136462619_136462773 | 7.91 |
Kif14 |
kinesin family member 14 |
3647 |
0.18 |
chr12_24593250_24593444 | 7.86 |
Grhl1 |
grainyhead like transcription factor 1 |
12598 |
0.17 |
chr10_61081034_61081185 | 7.85 |
Pcbd1 |
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 |
8222 |
0.14 |
chr1_164787925_164788307 | 7.83 |
Dpt |
dermatopontin |
8528 |
0.18 |
chr8_34455567_34455746 | 7.83 |
Gm45349 |
predicted gene 45349 |
17339 |
0.17 |
chr1_34435022_34435238 | 7.83 |
Gm37233 |
predicted gene, 37233 |
1866 |
0.14 |
chr18_73846769_73846920 | 7.83 |
Mro |
maestro |
12541 |
0.2 |
chr10_20241060_20241211 | 7.76 |
Map7 |
microtubule-associated protein 7 |
11340 |
0.14 |
chr11_69601181_69601332 | 7.74 |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
1485 |
0.15 |
chr17_46203290_46203452 | 7.72 |
Xpo5 |
exportin 5 |
554 |
0.44 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 12.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
3.8 | 11.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.4 | 13.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.3 | 9.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
2.7 | 8.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.4 | 7.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.3 | 9.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.3 | 9.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
2.2 | 6.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.2 | 15.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
2.1 | 6.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.1 | 4.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.1 | 10.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 6.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
2.0 | 11.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.0 | 5.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.9 | 7.7 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.8 | 1.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.7 | 5.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.7 | 5.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.7 | 5.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.7 | 6.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.7 | 5.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.6 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.6 | 14.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.6 | 6.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
1.6 | 6.3 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.6 | 6.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.5 | 4.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 4.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.4 | 4.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.4 | 4.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.4 | 4.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
1.4 | 4.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.3 | 5.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.3 | 6.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.3 | 6.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.3 | 2.5 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
1.3 | 6.3 | GO:0006265 | DNA topological change(GO:0006265) |
1.2 | 5.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.2 | 3.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.2 | 3.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.2 | 4.9 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.2 | 3.7 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.2 | 7.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.2 | 1.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.2 | 9.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.1 | 4.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.1 | 2.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.1 | 1.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.1 | 4.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.1 | 3.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.1 | 3.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
1.1 | 6.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.0 | 5.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.0 | 9.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 4.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.0 | 3.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 3.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.0 | 3.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.0 | 3.0 | GO:0021586 | pons maturation(GO:0021586) |
1.0 | 9.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.0 | 2.9 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.0 | 5.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.0 | 3.8 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 6.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.9 | 1.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.9 | 3.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.9 | 19.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.9 | 2.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 6.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 2.8 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.9 | 4.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.9 | 7.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.9 | 2.7 | GO:0015817 | histidine transport(GO:0015817) |
0.9 | 1.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.9 | 10.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 1.8 | GO:0048382 | mesendoderm development(GO:0048382) |
0.9 | 5.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.9 | 2.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.9 | 2.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.9 | 11.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.9 | 3.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 3.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.9 | 2.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.9 | 4.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.8 | 3.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 2.5 | GO:0036394 | amylase secretion(GO:0036394) |
0.8 | 3.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.8 | 4.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 4.1 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.8 | 2.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 2.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.8 | 18.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.8 | 3.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 2.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.8 | 3.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.8 | 3.9 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.8 | 15.4 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.8 | 2.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 3.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 1.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.7 | 12.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.7 | 2.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.7 | 1.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.7 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 1.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 6.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 16.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 1.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.7 | 2.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 2.2 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 3.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 2.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.7 | 2.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.7 | 4.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 1.4 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.7 | 2.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 11.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.7 | 4.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.7 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.8 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.7 | 2.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 2.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 4.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 3.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.7 | 2.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.7 | 2.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.7 | 2.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 2.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 2.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 2.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 3.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 1.3 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.6 | 1.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 1.9 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.6 | 5.6 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 11.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 1.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 1.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.6 | 2.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.6 | 1.8 | GO:0097484 | dendrite extension(GO:0097484) |
0.6 | 3.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 1.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 2.4 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.6 | 1.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 1.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 17.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 2.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 10.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.6 | 2.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 5.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 3.5 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 5.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.6 | 0.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.6 | 1.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 3.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 2.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 2.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 6.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.6 | 2.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.6 | 1.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 1.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 1.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.5 | 5.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 6.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 4.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 1.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 2.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 0.5 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 2.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 16.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.5 | 5.8 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 1.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 1.6 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 4.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.5 | 1.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 10.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.5 | 2.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 2.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 1.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 6.5 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.5 | 1.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 1.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 2.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 2.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 2.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 1.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.5 | 1.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 1.5 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 0.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 2.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 1.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 2.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 5.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 1.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 1.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 0.9 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 1.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 3.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.4 | 1.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 0.9 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.4 | 1.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 1.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 2.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 0.9 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 0.9 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 1.3 | GO:0048840 | otolith development(GO:0048840) |
0.4 | 2.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 2.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 2.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 2.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.7 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 2.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 2.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 3.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 3.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 3.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 2.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.4 | 1.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 5.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 2.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 1.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.8 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 2.4 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.4 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 1.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 0.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 1.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) regulation of relaxation of cardiac muscle(GO:1901897) |
0.4 | 0.4 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.4 | 2.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.4 | 1.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 11.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.4 | 1.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 2.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 3.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 2.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.9 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.4 | 1.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 1.9 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 0.7 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 2.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 0.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 4.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 1.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 1.5 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 0.4 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 1.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.4 | 2.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 5.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 1.1 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 0.4 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.4 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 2.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 2.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.4 | 4.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 5.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 3.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 1.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 2.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 4.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 2.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 2.0 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.3 | 0.7 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 2.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 3.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 1.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 2.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 3.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 1.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 1.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 3.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.7 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 4.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.3 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.3 | 2.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 2.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 2.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 1.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 1.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 1.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 1.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 3.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 2.1 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 0.9 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.3 | 1.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.3 | 2.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.6 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 0.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.3 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.3 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.3 | 2.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.3 | 0.9 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 0.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 1.7 | GO:0001660 | fever generation(GO:0001660) |
0.3 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 4.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 2.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 0.6 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 0.8 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 2.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 1.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 1.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 2.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 3.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 2.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 0.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 1.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.8 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.5 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.3 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 1.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.3 | 1.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 1.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 2.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 5.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.3 | 4.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.3 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 4.9 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.3 | 0.8 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 1.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 2.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 3.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 7.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 2.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 4.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.3 | 1.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 0.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 7.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 1.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 4.5 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 1.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 7.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.7 | GO:0070977 | bone maturation(GO:0070977) |
0.2 | 1.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 2.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 1.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 8.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.2 | 7.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 2.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 2.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
0.2 | 2.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 2.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 3.8 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 2.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.9 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 1.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 2.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 3.6 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 2.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.7 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.7 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.2 | GO:0003181 | atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 0.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.2 | GO:0003174 | mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) |
0.2 | 0.4 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 0.2 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.2 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.2 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 8.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 4.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 2.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 1.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 1.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 3.9 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 1.0 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.2 | 1.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 2.8 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.4 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.8 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 4.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.2 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 11.0 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.2 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.2 | GO:1902988 | regulation of tau-protein kinase activity(GO:1902947) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.2 | 0.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 3.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 1.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.4 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 1.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.7 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 2.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 4.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 1.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.4 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.7 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.7 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 2.8 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 3.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 2.7 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 5.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 0.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 1.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 3.9 | GO:0042755 | eating behavior(GO:0042755) |
0.2 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 3.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 2.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 3.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.5 | GO:0032371 | regulation of sterol transport(GO:0032371) regulation of cholesterol transport(GO:0032374) |
0.2 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.5 | GO:0061140 | Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.2 | 0.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0019230 | proprioception(GO:0019230) sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 1.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 9.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 1.6 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.2 | 3.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.5 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.4 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.2 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.6 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.6 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 1.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.4 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.1 | GO:0036515 | dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 4.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 2.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.8 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 2.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 1.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 1.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 1.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 3.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 1.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 2.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 1.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 2.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.5 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.4 | GO:0003283 | atrial septum development(GO:0003283) |
0.1 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 1.2 | GO:0072595 | maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 3.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 2.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.1 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.1 | 0.2 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.7 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 4.3 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.0 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:1904742 | protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.5 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.8 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.4 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 2.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.7 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 2.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 5.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 1.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 1.4 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
0.1 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 2.9 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.1 | GO:0098534 | centriole assembly(GO:0098534) |
0.1 | 7.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.8 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 2.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 2.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 1.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.5 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 2.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 2.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 1.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 2.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.5 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.7 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 2.8 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.1 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 1.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 1.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.1 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 1.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.4 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 1.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.6 | GO:0001947 | heart looping(GO:0001947) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.1 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 1.0 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 2.6 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 2.9 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 5.6 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 2.1 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.1 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.2 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.1 | 0.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.1 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.2 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:1902093 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.2 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0098930 | axonal transport(GO:0098930) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.7 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 2.1 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.0 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.3 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.2 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.2 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.0 | GO:0044321 | response to leptin(GO:0044321) |
0.0 | 0.4 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.0 | GO:0098597 | observational learning(GO:0098597) |
0.0 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.2 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.1 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 1.4 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.1 | GO:0032651 | regulation of interleukin-1 beta production(GO:0032651) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.3 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.0 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.7 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.0 | GO:0071694 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.0 | 0.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.0 | 0.1 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.0 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.8 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.2 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.0 | GO:0014014 | negative regulation of gliogenesis(GO:0014014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0097513 | myosin II filament(GO:0097513) |
2.1 | 6.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.1 | 20.6 | GO:0031932 | TORC2 complex(GO:0031932) |
1.8 | 5.3 | GO:0071942 | XPC complex(GO:0071942) |
1.6 | 6.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.4 | 7.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.4 | 14.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.3 | 5.2 | GO:1990357 | terminal web(GO:1990357) |
1.2 | 8.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 3.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.2 | 4.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.2 | 5.8 | GO:0097433 | dense body(GO:0097433) |
1.1 | 6.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 4.4 | GO:0030891 | VCB complex(GO:0030891) |
1.1 | 3.2 | GO:0005745 | m-AAA complex(GO:0005745) |
1.0 | 4.1 | GO:0005955 | calcineurin complex(GO:0005955) |
1.0 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 3.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.0 | 4.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 7.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.0 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 3.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 2.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 4.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 2.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 12.4 | GO:0000800 | lateral element(GO:0000800) |
0.9 | 0.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 7.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.8 | 4.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 2.5 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 2.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 6.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.7 | 11.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 2.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 5.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.7 | 5.0 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 2.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 2.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.7 | 4.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 2.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 1.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 2.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 2.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 2.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 5.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 4.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 3.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 3.4 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 4.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 4.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 2.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 2.7 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 4.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 4.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 0.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 1.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 2.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 12.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 12.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 1.9 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.8 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.4 | 2.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.4 | 2.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 4.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 9.7 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 10.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 9.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 4.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 3.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 1.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 0.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 7.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 3.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 36.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.3 | 1.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 1.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 5.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 1.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 3.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 2.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 5.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 13.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 4.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 2.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 3.6 | GO:0001741 | XY body(GO:0001741) |
0.3 | 2.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 3.8 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 5.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 15.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 7.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 10.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 0.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 3.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.2 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 3.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 0.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 30.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 7.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 16.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.7 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 8.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.0 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 2.9 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.7 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.3 | GO:0002102 | podosome(GO:0002102) |
0.2 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.2 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.2 | 2.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 4.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 2.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.2 | 4.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 2.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 4.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 4.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 3.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 14.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 7.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 3.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 4.4 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 2.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 16.4 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 0.7 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 11.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 4.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 5.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 3.7 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 28.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 1.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.8 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 22.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 12.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 6.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 6.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 5.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 2.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 23.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 3.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 2.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 7.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 4.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 2.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 6.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 73.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 2.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 4.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 2.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 5.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 110.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 7.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 68.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 4.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 2.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 2.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 25.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.3 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.6 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.8 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 96.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 1.4 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.1 | GO:0030894 | replisome(GO:0030894) |
0.0 | 4.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 4.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 13.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.9 | 8.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.5 | 12.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.3 | 16.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
2.2 | 6.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.1 | 6.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.9 | 13.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.9 | 5.7 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.8 | 7.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.7 | 5.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.7 | 15.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.7 | 5.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.5 | 4.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.5 | 6.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.5 | 10.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.5 | 14.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.3 | 5.4 | GO:0032564 | dATP binding(GO:0032564) |
1.3 | 3.8 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 9.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.2 | 3.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.2 | 8.3 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 6.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 3.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.1 | 12.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.1 | 3.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.1 | 7.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 5.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.0 | 4.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 4.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 6.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.0 | 11.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.0 | 10.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 2.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 3.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 2.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.9 | 1.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.9 | 3.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.9 | 11.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.8 | 10.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 2.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.8 | 4.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 3.9 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.8 | 5.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.8 | 6.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 3.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 2.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 8.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.7 | 0.7 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.7 | 4.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 3.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 2.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 0.7 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.7 | 4.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.7 | 4.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 20.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.7 | 2.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.7 | 2.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 2.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 3.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 3.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.6 | 4.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 3.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 3.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 2.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 14.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 1.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.6 | 1.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.6 | 12.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 3.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 2.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 1.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.6 | 9.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.6 | 2.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 3.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 3.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 2.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 1.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 13.7 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.5 | 3.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 3.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 3.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 1.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 3.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 3.6 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 3.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 2.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 5.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 7.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 1.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 5.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 5.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 0.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 1.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 3.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 10.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 6.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 2.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 5.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 1.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 3.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 1.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 5.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 6.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 4.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.4 | 27.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.4 | 2.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 4.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 3.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 8.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 2.9 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 1.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 7.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 7.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 5.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 1.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 3.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 3.6 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 2.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 0.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.3 | 1.6 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 1.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 1.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 3.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 0.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 6.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 8.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 3.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 2.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 5.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 9.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 5.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 3.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 3.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 2.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.9 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 15.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 7.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 7.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.7 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 2.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 2.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 2.3 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 2.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 4.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.5 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.2 | 12.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 5.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 2.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 3.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.6 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 4.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 9.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 2.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 2.3 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 3.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 2.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 1.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 9.6 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 5.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 9.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 14.5 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 2.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 2.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 6.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 7.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 1.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.7 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 5.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 4.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 7.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 2.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 4.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 13.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 7.7 | GO:0008921 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) O antigen polymerase activity(GO:0008755) lipopolysaccharide-1,6-galactosyltransferase activity(GO:0008921) cellulose synthase activity(GO:0016759) 9-phenanthrol UDP-glucuronosyltransferase activity(GO:0018715) 1-phenanthrol glycosyltransferase activity(GO:0018716) 9-phenanthrol glycosyltransferase activity(GO:0018717) 1,2-dihydroxy-phenanthrene glycosyltransferase activity(GO:0018718) phenanthrol glycosyltransferase activity(GO:0019112) alpha-1,2-galactosyltransferase activity(GO:0031278) dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0033556) endogalactosaminidase activity(GO:0033931) lipopolysaccharide-1,5-galactosyltransferase activity(GO:0035496) dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042283) inositol phosphoceramide synthase activity(GO:0045140) alpha-(1->3)-fucosyltransferase activity(GO:0046920) indole-3-butyrate beta-glucosyltransferase activity(GO:0052638) salicylic acid glucosyltransferase (ester-forming) activity(GO:0052639) salicylic acid glucosyltransferase (glucoside-forming) activity(GO:0052640) benzoic acid glucosyltransferase activity(GO:0052641) chondroitin hydrolase activity(GO:0052757) dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity(GO:0052824) cytokinin 9-beta-glucosyltransferase activity(GO:0080062) |
0.2 | 5.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 3.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.7 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 7.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 2.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 2.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 3.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 3.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 5.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 7.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 5.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 1.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 6.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 16.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 7.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 4.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 2.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0018646 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 3.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.6 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 20.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 2.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 2.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 4.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.5 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 2.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 3.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 3.4 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 10.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 5.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 5.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 10.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 2.1 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 3.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 1.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 2.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 4.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 2.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.4 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 4.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.2 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 5.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 13.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 1.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.8 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 2.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.7 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 2.4 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.0 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) oleic acid binding(GO:0070538) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.6 | 1.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.3 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.0 | 3.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.9 | 13.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 0.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.8 | 4.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 4.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.7 | 29.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 17.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 3.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 3.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 8.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 9.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 6.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 20.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 10.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 7.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 15.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 8.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 9.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 2.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 3.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 2.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 18.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 19.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 9.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 8.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 2.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 2.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 3.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 18.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 3.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 41.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 3.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 5.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 8.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 8.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 8.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 8.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 4.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 3.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 6.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 4.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 9.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 1.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 4.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 17.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 11.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 5.5 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 26.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.1 | 16.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.0 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.8 | 10.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 11.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 6.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 6.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 4.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 7.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 14.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 6.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.6 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 8.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 6.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 3.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 13.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 9.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 1.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 7.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 5.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 4.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 4.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 5.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 3.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 7.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 1.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 6.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 4.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 4.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 6.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 7.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 8.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 5.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 8.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 1.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 3.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 2.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 4.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 3.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 15.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 3.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 3.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 8.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 24.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 3.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 8.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 2.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 5.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 5.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 2.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 4.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 13.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 4.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 5.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 2.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 10.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 1.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 5.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 7.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 0.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 2.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 11.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 8.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 4.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 6.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 1.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 2.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 4.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 2.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 1.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 14.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 1.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 4.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 2.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 4.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 5.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 2.3 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 2.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 5.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 2.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 4.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |